Harsha targets June 2027 for Rs 220 crore expansion spend

Harsha Engineers International Limited expects to finish spending its announced Rs 220 crore on India and China expansion projects by June 2027, accelerating the initially indicated 18-month schedule to roughly 12 to 15 months. Management said customer approvals and trials could nevertheless push commercial go-live beyond the completion of spending.

When will Harsha complete its India and China capex?

Harsha expects the spending on both expansion sites to be completed by about June 2027, with execution taking 12 to 15 months depending on the project. Management had initially described the combined India and China capital-expenditure, or capex, programme as an 18-month exercise, but said it is now accelerating expenditure at both locations.

The revised timetable applies to the completion of capex spending rather than necessarily to production revenue. Management drew that distinction because equipment or expanded capacity may require customer approvals and trials after spending is completed. Thus, June 2027 is management’s expectation for completing the outlay, not a stated deadline for every project to begin commercial operations.

The change is material because it brings forward the deployment of the announced Rs 220 crore programme by roughly three to six months versus the original 18-month indication. Harsha did not provide a quarter-by-quarter spending schedule for financial year 2027, or FY27, but said the pace had increased in both India and China.

How is Harsha’s Rs 220 crore expansion capex divided?

Harsha has allocated about Rs 110 crore to its India expansion and about Rs 100 crore to its China Phase 2 expansion, for approximately Rs 220 crore in total. The India investment is mainly for the next phase of Harsha Advantek’s expansion, while management described the China allocation as an already announced Phase 2 project.

The India allocation is Rs 10 crore larger than the China Phase 2 allocation. That difference is limited relative to the full Rs 220 crore programme, but it shows that Harsha is committing broadly similar amounts to the domestic Harsha Advantek expansion and the overseas China capacity project.

Management linked the India project specifically to Harsha Advantek, rather than describing it as routine spending across the parent business. Separately, it said Harsha Advantek’s overall capex could exceed Rs 350 crore once its phase expansion and new building plan are complete, including more than Rs 100 crore for building and infrastructure. That broader figure is distinct from the Rs 110 crore India amount discussed for the next 12 to 15 months.

How much has Harsha spent and what is its regular capex requirement?

Harsha said first-half, or H1, spending was about Rs 70 crore plus against the Rs 220 crore announced India and China programme. Management gave that figure after an analyst cited consolidated H1 capex of Rs 73 crore, and said the balance would be deployed as the company accelerates the two projects.

The H1 spend means a meaningful portion of the announced programme has already been incurred, while most of the Rs 220 crore remains to be completed by the targeted June 2027 date. The earlier full-year interpretation of Rs 50 crore to Rs 80 crore was rejected by management as a misreading, which matters because the Rs 220 crore plan spans more than one financial year rather than representing only FY27 outlay.

Harsha estimated ongoing maintenance and operational capex at Rs 25 crore to Rs 30 crore annually on a consolidated basis. That recurring amount includes requirements at the China and Romania sites, making it separate from the Rs 220 crore expansion programme for India and China.

The comparison shows that routine spending is much smaller than the current expansion commitment. At the upper end, Rs 30 crore of annual maintenance capex is about one-seventh of Rs 220 crore of announced expansion spending, underscoring that the accelerated expenditure is project-led rather than ordinary upkeep.

What could delay production after Harsha completes the spending?

Customer approvals and trials are the stated factors that could delay commercial go-live after Harsha completes capex spending by June 2027. Management did not quantify the possible delay or identify individual customers, so the transcript does not establish when either the India or China additions will generate revenue.

This distinction is especially relevant for Harsha Advantek because management said first-phase expansion had already been completed and was carrying incremental operating expenses, interest and depreciation. It expects Harsha Advantek to contribute positively in the second half, or H2, of FY27, although it cautioned that H2 profitability might not fully offset the approximately Rs 7 crore loss reported in H1.

Harsha also said it was not assuming incremental borrowings in FY28 for these projects. Management said borrowing already taken was for the Harsha Advantek expansion and China Phase 2, and added that it had no specific debt-reduction plan because current debt was associated with lower interest rates or government subsidy support.

For Harsha Advantek, management expects total capex loans of around Rs 250 crore at the overall project level, with the remaining funding coming from Harsha. It estimated combined interest and depreciation at around Rs 7.5 crore to Rs 8 crore currently, potentially rising to a maximum of Rs 10 crore once the expansion is fully in place. These figures concern the broader Harsha Advantek build-out and should not be treated as a separate funding breakdown for the Rs 110 crore India allocation.

Conclusion

Harsha is accelerating a roughly Rs 220 crore, two-country investment programme, with the target shifting from an indicated 18 months to 12 to 15 months and spending expected to finish by June 2027. The programme is split almost evenly between Rs 110 crore for India, mainly Harsha Advantek’s next phase, and Rs 100 crore for China Phase 2, while regular consolidated maintenance capex remains Rs 25 crore to Rs 30 crore a year.

The next points to watch are the pace of the remaining spend through June 2027 and customer approvals and trials that could postpone commercial production after capex completion. Management’s H2 FY27 expectation for Harsha Advantek to turn profit positive, alongside its plan not to assume incremental FY28 borrowing, will also indicate how the expansion is affecting operating costs, financing and execution.